An intravaginal ring, developed by Northwestern scientist Patrick Kiser, is the first device to be tested in women with the potential to protect against HIV, herpes and unwanted pregnancy.
The team of six students developed a winning business plan for a patented, personalized therapy that stimulates the immune system to fight breast cancer.
Serdar Bulun, MD, authored an article in the New England Journal of Medicine that combines recent uterine fibroid research into a useful framework for scientists, clinicians, patients and the pharmaceutical industry.
A new intravaginal ring filled with an anti-retroviral drug demonstrated a 100 percent success rate protecting primates from the simian human immunodeficiency virus (SHIV).
Amidst the presentations and poster sessions, faculty from Northwestern University Feinberg School of Medicine were honored with a pair of major recognitions at the Endocrine Society’s 95th annual meeting.